Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen's MS Drugs Ride High In India, Backed By Special Pricing, Awareness Building And Pharmacovigilance

Jun 13 2011

• By PharmAsia News

Related Content

U.S. Tysabri Labeling Updated With More PML Risk Info But No Reference To JCV Testing

Apr 22 2011

Biogen Idec's BG-12 Results Up The Ante In The Oral MS Market

Apr 21 2011

"With A Molecule That Is A Million Times Larger Than A Small Molecule, So Many Things Can Go Wrong," Says Biogen Idec Asia Operations Head Gunther Winkler

Jan 11 2010

Sneak Preview: BCG Study Predicts Strong R&D Focus In India; Big Pharma May Leverage India For "Niche Busters" And Stem Cells

May 23 2011

Biogen Set For Avonex Launch In India, But Concerned About Biosimilars Regulations

Dec 04 2009

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window